Fifth Third Bancorp Curis Inc Transaction History

Fifth Third Bancorp

  • $27.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 05, 2020
SELL
$0.63 - $1.7 $3 - $10
-6 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.36 - $2.44 $8 - $14
6 New
6 $0
Q2 2019

Aug 07, 2019
SELL
$1.36 - $2.35 $136 - $235
-100 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$0.78 - $2.01 $78 - $200
100 New
100 $0

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email